US Patent 8968741 Anti-CD22 antibodies and immunoconjugates and methods of use

Patent 8968741 was granted and assigned to Genentech on March, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8968741

Date of Patent

March 3, 2015

Patent Application Number

13760751

Date Filed

February 6, 2013

Patent Citations Received

‌

US Patent 11945882 Method for producing antibody-drug conjugate

‌

US Patent 11692041 Antibody molecules which bind CD45

‌

US Patent 11872289 Anti-MUC1 antibody-drug conjugate

Patent Primary Examiner

‌

Phuong Huynh

Patent abstract

Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8968741 Anti-CD22 antibodies and immunoconjugates and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API